Biodegradable microspheres for protein delivery

Cohen, 1991, Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres, Pharm. Res., 8, 713, 10.1023/A:1015841715384

Banga, 1988, Systemic delivery of therapeutic peptides and proteins, Int. J. Pharm., 48, 15, 10.1016/0378-5173(88)90246-3

Lee, 1987, Ophthalmic delivery of peptides and proteins, Pharm. Technol, 11, 26

Shire, 1987, Formulation design of protein pharmaceuticals, Pharm. Technol., 11, 34

Lee, 1986, Peptide and protein drug delivery: opportunities and challenges, Pharm. Int., 7, 208

Tice, 1989, 223

Hermann, 1995, The effect of particle micro structure on the somatostatin release from poly(lactide) microspheres prepared by a w/o/w solvent evaporation method, J. Control. Release, 36, 63, 10.1016/0168-3659(95)00051-9

Takada, 1995, Application of a spray drying technique in production of TRH-containing injectable sustained release microparticles of biodegradable polymers, J. Pharm. Sci. Technol., 49, 180

Jalil, 1990, Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties, J. Microencapsul., 7, 297, 10.3109/02652049009021842

Yolles, 1971, Sustained delivery of drugs from polymer drug mixtures, Polym. News., 1, 9

Sanders, 1985, Controlled delivery of LHRH analogues from biodegradable injectable microspheres, J. Control. Release., 2, 187, 10.1016/0168-3659(85)90044-6

Rogers, 1993, Formulations of antibiotics in polymeric microcapsules: ciprofloxacin, 24

Brannon-Peppas, 1994, Drug delivery of penicillin and β-estradiol from biodegradable microparticles within degradable and nondegradable films, 27

Fujita, 1992, Delivery of amikacin from an aerosolid biodegradable film, 15

Cowsar, 1985, Poly(lactide-co-glycolide) microcapsules for controlled release of steroids, Methods Enzymol., 112, 101, 10.1016/S0076-6879(85)12010-0

Eldridge, 1993, Protection against vaginal SIV transmission with microencapsulated vaccine, Science, 260, 1323, 10.1126/science.8493576

Moore, 1995, Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytoxic T lymphocytes and CD4+ Th1 cells, Vaccine, 13, 1741, 10.1016/0264-410X(95)00184-3

Bittner, 1998, Recombinant human erythropoietin (rHEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microspheres characteristics, Eur. J. Pharm. Biopharm., 45, 295, 10.1016/S0939-6411(98)00012-5

Ando, 1999, PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization, J. Pharm. Sci., 88, 126, 10.1021/js9801687

Wang, 1999, Encapsulation of plasmid DNA in biodegradable poly(d,l-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery, J. Control. Release, 57, 9, 10.1016/S0168-3659(98)00099-6

Fattal, 1998, Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides, J. Control. Release, 53, 137, 10.1016/S0168-3659(97)00246-0

Lewis, 1998, Development of a sustained release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro, J. Drug Target., 5, 291, 10.3109/10611869808995882

Humphrey, 1986, Peptide and related drugs: a review of their absorption metabolism and excretion, Drug. Metab. Rev., 17, 283, 10.3109/03602538608998293

L Lee, 1991, Mucosal penetration enhancers for facilitation of peptide and protein drug absorption, Crit. Rev. Ther. Drug Carrier Syst., 8, 91

Merkle, 1994, New aspects of pharmaceutical dosage forms for controlled drug delivery of peptides and proteins, Eur. J. Pharm. Sci., 2, 19, 10.1016/0928-0987(94)90054-X

Lehr, 1994, Bioadhesion technologies for the delivery of peptides and protein drugs to GIT, Crit. Rev. Ther. Drug Carrier Syst., 11, 119

Sarciaux, 1995, Using microemulsion formulations for oral drug delivery of therapeutic peptides, Int. J. Pharm., 120, 27, 10.1016/0378-5173(94)00386-J

Pearlman, 1993, 1

Manning, 1989, Stability of protein pharmaceuticals, Pharm. Res., 6, 903, 10.1023/A:1015929109894

Volkin, 1992, 109

Zale, 1986, Why does ribonuclease irreversibly inactivate at high temperatures?, Biochemistry, 25, 5432, 10.1021/bi00367a014

Johnson, 1999, Peptide and protein drug delivery, Vol. 2, 816

Wang, 1996, Oral protein drug delivery, J. Drug Target., 4, 195, 10.3109/10611869608995624

de Bore, 1992, Rate controlled rectal peptide drug absorption, Adv. Drug. Deliv. Rev., 8, 237

Ho, 1992, Mechanistic insights to buccal delivery of proteinaceous substances, Adv. Drug. Deliv. Rev., 8, 197, 10.1016/0169-409X(92)90003-9

Cullander, 1992, Transdermal delivery of peptides and proteins, Adv. Drug. Deliv. Rev., 8, 291, 10.1016/0169-409X(92)90006-C

Hirai, 1981, Effects of surfactants on the nasal absorption of insulin in rats, Int. J. Pharm., 9, 165, 10.1016/0378-5173(81)90009-0

Lee, 1987, Ophthalmic delivery of peptides and proteins, Pharm. Technol., April, 26

Madara, 1985, Occluding junction structure-function relationships in a cultured epithelial monolayer, J. Cell. Biol., 101, 2124, 10.1083/jcb.101.6.2124

Modi, 1994, Pharmacokinetics and pharmacodynamics of recombinant proteins and peptides, J. Control. Release, 29, 269, 10.1016/0168-3659(94)90073-6

Zhou, 1994, Overcoming enzymatic and absorption barriers to non –parenterally administered protein and peptide drugs, J. Control. Release, 29, 239, 10.1016/0168-3659(94)90071-X

Webber, 1999, Mucosal drug delivery: buccal, 553

Potts, 1997, 213

Porter, 1994, Microparticulate system for site-specific therapy-bone marrow targeting

Davis, 1985, The influence of emulsifying agents on the phagocytosis of lipid emulsions by macrophages, Int. J. Pharm., 23, 69, 10.1016/0378-5173(85)90223-6

Illum, 1983, Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration, J. Pharm. Sci., 72, 1086, 10.1002/jps.2600720933

Torchilin, 1994, Hypothesis: why do PEG coated liposomes circulate so long?, J. Liposome Res., 4, 725

Miller, 1997, Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymers ratio, J. Biomed. Mater. Res., 11, 711, 10.1002/jbm.820110507

Murthy, 1997, Biodegradable polymers, 27

Lewis, 1990, Controlled release of bioactive agents from lactide/glycolide polymers, 9

Lewis, 1990, Vol. 45, 1

Jeyanthi, 1997, Effect of processing parameters on the properties of peptide-containing PLGA microspheres, J. Microencapsul., 14, 163, 10.3109/02652049709015330

Timpi, 1976, 55

Hunter, 2001, Biodegradable microspheres containing group B Streptococcus vaccine: immune response in mice, Am. J. Obstet. Gynecol., 185, 1174, 10.1067/mob.2001.117658

Jung, 2002, Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice, Int. J. Pharm., 234, 75, 10.1016/S0378-5173(01)00957-7

Khang, 1999, Preparation and characterization of Japanese encephalitis virus vaccine loaded poly(l-lactide-co-glycolide) microspheres for oral immunization, Biomed. Mater. Eng., 9, 49

Johansen, 1999, Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs, Vaccine, 18, 209, 10.1016/S0264-410X(99)00191-7

Yeh, 2002, Oral immunogenicity of the inactivated Vibrio cholerae whole cell vaccine encapsulated in biodegradable microparticles, J. Control. Release, 82, 237, 10.1016/S0168-3659(02)00140-2

Genta, 2001, Enzyme loaded biodegradable microspheres in vitro ex vivo evaluation, J. Control. Release, 77, 287, 10.1016/S0168-3659(01)00511-9

Fattal, 2002, Oral tolerance induced by poly(lactide-co-glycolide) containing B lactoglobulin, Ann. Pharm. Fr., 60, 44

Zhou, 2002, Study on biodegradable microspheres containing recombinant interferon-alpha-2a, J. Pharm. Pharmacol., 54, 1287, 10.1211/002235702320402143

Yeh, 2000, The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol, J. Microencapsul., 7, 743, 10.1080/02652040050161738

Nam, 2000, Lysozyme microencapsulation within biodegradable PLGA microspheres: urea effect on protein release and stability, Biotechnol. Bioeng., 70, 270, 10.1002/1097-0290(20001105)70:3<270::AID-BIT4>3.0.CO;2-8

Rosas, 2002, Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immnunisation of SPf66 encapsulated in PLGA microspheres, Vaccine, 20, 1707, 10.1016/S0264-410X(01)00508-4

Boehm, 2002, On technological and immunological benefits of multivalent single-injection microsphere vaccines, Pharm. Res., 19, 1330, 10.1023/A:1020354809581

Sturesson, 1999, Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres, J. Control. Release, 59, 377, 10.1016/S0168-3659(99)00014-0

Han, 2001, Preparation and evaluation of poly(l-lactic acid) microspheres containing rhEGF for chronic gastric ulcer healing, J. Control. Release, 75, 259, 10.1016/S0168-3659(01)00400-X

Morlock, 1998, Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties, J. Control. Release, 56, 105, 10.1016/S0168-3659(98)00070-4

Zambaux, 1999, Preparation and characterization of protein C loaded PLA nanoparticles, J. Control. Release, 60, 179, 10.1016/S0168-3659(99)00073-5

Jackson, 2002, The encapsulation of ribozymes in biodegradable polymeric matrices, Int. J. Pharm., 243, 43, 10.1016/S0378-5173(02)00228-4

Blanco-Prieto, 2000, In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres, J. Control. Release, 67, 19, 10.1016/S0168-3659(99)00289-8

Yuksel, 2000, De novo adipose tissue generation through long-term, local delivery of insulin and insulin like growth factor-1 by PLGA/PEG microspheres in an in vivo rat model: a novel concept and capability, Plast. Reconstruct. Surg., 105, 1721, 10.1097/00006534-200004050-00018

Kostanski, 2000, Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres, Pharm. Dev. Technol., 5, 585, 10.1081/PDT-100102043

King, 2000, Development and in vitro characterization of vascular endothelial growth factor (VEGF) loaded poly(dl-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique, J. Biomed. Mater. Res., 51, 383, 10.1002/1097-4636(20000905)51:3<383::AID-JBM12>3.0.CO;2-D

Cho, 2000, Effects of solvent selection and fabrication on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin, Arch. Pharm. Res., 23, 385, 10.1007/BF02975452

Zhu, 2001, Preparation and characterization of hCG loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in water (w/o/w) emulsion solvent evaporation technique, J. Microencapsul., 18, 247, 10.1080/02652040010000474

Li, 2001, In vitro protein release and degradation of poly-dl-lactide-poly(ethylene glycol) microspheres with entrapped human serum albumin: quantitative evaluation of the factors involved in protein release phases, Pharm. Res., 18, 117, 10.1023/A:1011043230573

Schrier, 1999, Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems, Pharm. Dev. Technol., 4, 611, 10.1081/PDT-100101400

Carrasquillo, 2001, Non-aqueous encapsulation of excipient stabilized spray freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein, J. Control. Release, 76, 199, 10.1016/S0168-3659(01)00430-8

Prabhu, 2002, Comparative assessment of in vitro release kinetics of calcitonin polypeptide from biodegradable microspheres, Drug. Deliv., 9, 195, 10.1080/15227950290097633

Kissel, 1991, Parenteral depot systems as the basis of biodegradable polyesters, J. Control. Release, 16, 27, 10.1016/0168-3659(91)90028-C

Hilbert, 1999, Biodegradable microspheres containing influenza-A vaccine: immune response in mice, Vaccine, 17, 1065, 10.1016/S0264-410X(98)00323-5

Yang, 2001, Morphology, drug distribution and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double emulsion solvent extraction/evaporation method, Biomaterials, 22, 231, 10.1016/S0142-9612(00)00178-2

Ogawa, 1988, Controlled release of leuprolide acetate from polylactic acid or co-polymer ratio of polymer, Chem. Pharm. Bull., 36, 1502, 10.1248/cpb.36.1502

Redding, 1984, Long acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of DTrp6 leutinizing hormone releasing hormone injectable microcapsules, Proc. Natl. Acad. Sci. USA, 81, 5845, 10.1073/pnas.81.18.5845

Carpenter, 1997, Rational design of stable lyophilized protein formulations: some practical advice, Pharm. Res., 14, 969, 10.1023/A:1012180707283

Carpenter, 1989, An infrared spectroscopic study of the interactions of carbohydrates with dried proteins, Biochemistry, 28, 3916, 10.1021/bi00435a044

Arakawa, 1991, Protein solvent interactions in pharmaceutical formulations, Pharm. Res., 8, 285, 10.1023/A:1015825027737

Loftsson, 1996, Pharmaceutical applications of cyclodextrins. 1. Drug solubilisation and stabilization, J. Pharm. Sci., 85, 1017, 10.1021/js950534b

Rajewski, 1996, Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery, J. Pharm. Sci., 85, 1142, 10.1021/js960075u

Charman, 1993, Techniques for assessing the effects of pharmaceutical excipients on the aggregation of porcine growth hormone, Pharm. Res., 10, 954, 10.1023/A:1018994102218

Tsai, 1993, Formulation design of acidic fibroblast growth factor, Pharm. Res., 10, 649, 10.1023/A:1018939228201

Thurow, 1984, Stabilization of dissolved proteins against denaturation at hydrophobic interfaces, Diabetologia, 27, 212, 10.1007/BF00273809

Cunningham, 1991, Dimerization of human growth hormone by zinc, Science, 253, 545, 10.1126/science.1907025

Hanson, 1992, 209

Hora, 1992, Lyophilised formulations of recombinant tumor necrosis factor, Pharm. Res., 9, 33, 10.1023/A:1018919508463

Powell, 1991, Parenteral peptide formulations: chemical and physical properties of native luteinizing hormone-releasing hormone (LHRH) and hydrophobic analogues in aqueous solution, Pharm. Res., 8, 1258, 10.1023/A:1015847628047

Ressing, 1992, The influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody(MN12), Pharm. Res., 9, 226, 10.1023/A:1018905927544

Zhu, 2000, Stabilisation of proteins encapsulated in injectable poly(lactide-co-glycolide) polymers, Nat. Biotech., 18, 52, 10.1038/71916

Johnson, 1996, A month long effect from a single injection of microencapsulated human growth hormone, Nat. Med., 2, 795, 10.1038/nm0796-795

Visscher, 1987, Tissue response to biodegradable injectable microcapsules, J. Biomater. Appl., 2, 118, 10.1177/088532828700200103

Cleland, 1993, Development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation, Crit. Rev. Ther. Drug. Carrier Syst., 10, 307

International Conference On Harmonization, Fed. Regist. 62 (1997) 24302–24309.

Niu, 1998, FDA perspective on peptide formulation and stability issues, J. Pharm. Sci., 87, 1331, 10.1021/js9800782

Marchant, 1984, In vivo leukocyte interactions with biomer, J. Biomed. Mater. Res., 18, 1169, 10.1002/jbm.820180917

Sewell, 1955, A new method of comparing ovine catgut with sutures of bovine catgut in 3 species, Surg. Gynecol. Obstet., 100, 483

Gourlay, 1978, Biocompatibility testing of polymers: in vivo implantation studies, J. Biomed. Mater. Res., 12, 219, 10.1002/jbm.820120207

Bronaugh, 1982, 51

Foster, 1982, 99

Autian, 1983, 63

Imai, 1983, Structure-biocompatibility relationship of condensation polymers, J. Biomed. Mater. Res., 17, 905, 10.1002/jbm.820170602